Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. - Test2 - elhamkhani - TriplyDB

Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.

Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.

http://www.wikidata.org/entity/Q37409860

about

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens White paper report of the 2011 RAD-AID Conference on International Radiology for Developing Countries: integrating multidisciplinary strategies for imaging services in the developing world Determination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging.Extensively drug-resistant tuberculosis in a young child after travel to India.Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment 18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series.Molecular imaging reveals a progressive pulmonary inflammation in lower airways in ferrets infected with 2009 H1N1 pandemic influenza virus.Noninvasive determination of 2-[18F]-fluoroisonicotinic acid hydrazide pharmacokinetics by positron emission tomography in Mycobacterium tuberculosis-infected mice Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography.Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models Peripancreatic Tuberculous Lymphadenitis Diagnosed via Endoscopic Ultrasound-guided Fine-needle Aspiration and Polymerase Chain Reaction.Evaluation of standard chemotherapy in the guinea pig model of tuberculosis Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.Deficiency of double-strand DNA break repair does not impair Mycobacterium tuberculosis virulence in multiple animal models of infection.Nuclear imaging: a powerful novel approach for tuberculosis.Segmentation of PET images for computer-aided functional quantification of tuberculosis in small animal models.Gene expression of Mycobacterium tuberculosis putative transcription factors whiB1-7 in redox environments.Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in mice.Modeling tuberculosis in nonhuman primates.In vivo prediction of tuberculosis-associated cavity formation in rabbits The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets Imaging the evolution of reactivation pulmonary tuberculosis in mice using 18F-FDG PET Clinical and radiographic differentiation of lung nodules caused by mycobacteria and lung cancer: a case-control study.Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.Imaging Chronic Tuberculous Lesions Using Sodium [(18)F]Fluoride Positron Emission Tomography in Mice.Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum

P2860

Q26823503-614D7C42-F632-432C-A137-BBBDC204B2DA Q26852810-A3E76361-777C-49DA-94E9-BC51A397F732 Q27015115-196161D6-AFCD-43B0-B5B4-FE66F35D7968 Q27324299-5E23192E-EC2B-470C-BF3F-5321F0495B6D Q28270240-FFC069E2-466B-40CC-8C4A-289914B4A618 Q28385840-BD8DCF25-F663-423F-A3A2-F78AA4BCE75B Q28391110-F18E0774-2A11-4162-B7A3-4CC424E535F0 Q28477456-C8353FD2-AD83-473B-A244-24357CDB1058 Q30419743-290F49D1-6D6F-461F-8AE5-D61A8190911C Q30420539-7CAD2794-152D-4550-835C-B3EE55AE8F91 Q30421576-C8FDD3FB-AD82-484C-93CC-C81EAD74AD3B Q30620442-B7FB50FA-8D20-4380-8438-9C7FB02282A8 Q33589762-68E5E2E6-1223-4EE1-8AA5-25BFFA449366 Q33818713-8D19C21F-B915-460A-B62E-5E146A46F18A Q33826439-56D47D21-3834-45B2-876F-00B684CACB06 Q33981892-278EBD62-0823-4BE3-9AED-6D3BB882A5A4 Q34058944-E31CB0FF-74C6-4B3F-A748-07314609CDAA Q34315731-09C3028D-BE74-4773-832A-011C521D5002 Q34337141-D5D831F8-37DB-4972-B983-617DC559ECFF Q34351002-BFC41CA2-E734-4126-A9E3-674DA7ADF227 Q34923025-E29A808A-20F4-425B-83B5-26234D92063C Q34930509-992E7353-B27B-400B-8D65-6ACEB160DF2D Q34974767-92379CC9-F029-4A7E-A835-6CD13A5D9748 Q35076888-52CA7AB1-B23C-485D-A0EA-914D1AFA6ACD Q35598474-D38F2717-DF77-4531-AA6D-E748A127FCE2 Q35687128-032891B2-F246-4751-9E7B-2CA84499A322 Q35694718-5F2E89D3-5F86-422C-857F-2DD7F160B92A Q35745991-7459DAE5-2C78-45A0-8065-9CA9E4F0DE9F Q35800311-336DD660-B8BC-4F33-AF16-547F65E835CF Q35826719-E5822152-83A0-4CF3-B3BE-4F45BF9519B0 Q36018542-CCF67592-435F-46DD-ADCD-D0EA6DD5E970 Q36018624-DE274654-D484-4BBA-8316-AFAAFEE8C623 Q36032889-7F6DB189-0E05-46C9-A155-22D35157796A Q36086369-F5F06BD8-0EED-4A30-BD41-0D4B950BA462 Q36171524-FF97E7AC-DE4B-4EA6-8DD1-ED288E40D55F Q36171653-36C680DC-9CCD-4C82-925A-4B36138FB709 Q36267526-CE744A1E-0463-4611-AB4E-F01409946B25 Q36312141-586CF9A5-90FB-475A-BBFF-E43E097807D1 Q36571928-E1B380A9-A0F8-4826-89B8-FB36C7791DF7 Q36571981-D32D0893-D5E2-40AF-9B59-771015176F5E

P2860

Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.

http://www.wikidata.org/entity/Q37409860

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Noninvasive pulmonary [18F]-2- ...... f tuberculosis drug treatment.

@en

Noninvasive pulmonary [18F]-2- ...... f tuberculosis drug treatment.

@nl

type

label

Noninvasive pulmonary [18F]-2- ...... f tuberculosis drug treatment.

@en

Noninvasive pulmonary [18F]-2- ...... f tuberculosis drug treatment.

@nl

prefLabel

Noninvasive pulmonary [18F]-2- ...... f tuberculosis drug treatment.

@en

Noninvasive pulmonary [18F]-2- ...... f tuberculosis drug treatment.

@nl

P1433

Q37409860-7DFB0D75-31A3-4A39-BA57-C56F19D24162

P1476

Q37409860-164D4CD4-AB42-45DB-A25C-EDDB4EF550B1

P2093

Q37409860-0D9C79EC-6F72-4C0C-8079-6C039C3E10F2

Q37409860-3892FF60-65FF-4BEE-85A0-4083977BFE43

Q37409860-54F8E335-F9D3-4AB3-9E9E-52BCF92050A0

Q37409860-5EEEA8E1-98C6-460E-AFD3-C10297D91342

Q37409860-73792462-DA48-4517-ADDE-246349A95D58

Q37409860-8B84A359-E053-4AA1-A49F-E941168158E4

Q37409860-9CDB5AF5-6939-4D63-96F9-090E34FE7778

Q37409860-F0B34CA4-8441-45D7-A1C8-175B3D6F3AD6

P2860

Q37409860-0EE7DB58-2040-4635-BCC7-0C58C33DE7CF

Q37409860-24B13E8E-1FE3-4C03-BCA1-F41C55816F96

Q37409860-2AB1435B-D431-4C6C-A3BF-6803ABD01217

Q37409860-2B075A36-ECF5-49A1-8218-3E226C3C410D

Q37409860-2F7E06AF-B8C0-4139-A8E0-35FBAED4E1A1

Q37409860-3D82F3BE-91B6-487F-A7D9-6F0B637F06F1

Q37409860-483A2ECF-AFC8-4677-A0A7-A10D18B9360A

Q37409860-4B983427-255B-43DB-B6B3-EFDC43F4A421

Q37409860-642D311F-222D-471A-A76A-78EBE7453811

Q37409860-656CA9EE-F43A-4EEF-ACE9-CF0DB84F4C3D

P304

Q37409860-CAB1DB6E-B0C6-49E2-8ACD-115CF8C8D17A

P31

Q37409860-7FD4F578-FE5D-472F-9C46-D15777EFC43C

P356

Q37409860-2795EDB9-AB8B-434B-85A3-BD941D65DCF6

P407

Q37409860-53B68BF8-ACCA-4362-9D57-2017BDD9806B

P433

Q37409860-F1925161-2B00-475B-9C05-C98C69B055D3

P478

Q37409860-5DE8B7A7-45AB-4180-B2AA-7EFBD5CBDDFA

P577

Q37409860-0C88EF1E-5AE0-4454-BEA3-A554F6C9FF71

P698

Q37409860-64CEA232-60F0-49B7-B58D-312B38D05A8F

P921

Q37409860-7cce3145-841f-4b4d-aae3-4ba2a0f767df

Q37409860-9A57D69C-EE90-43DA-B01F-C6318149CA75

Q37409860-9F611C14-8733-4A8A-83F2-BD7497A38F1B

P932

Q37409860-A45326E6-8B3F-451D-9E77-3A10E8A99060

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Noninvasive pulmonary [18F]-2- ...... f tuberculosis drug treatment.

@en

P2093

Bruno Jedynak

http://www.w3.org/2001/XMLSchema#string

Camille Vidal

http://www.w3.org/2001/XMLSchema#string

Eric L Nuermberger

http://www.w3.org/2001/XMLSchema#string

Martin G Pomper

http://www.w3.org/2001/XMLSchema#string

Peter K Um

http://www.w3.org/2001/XMLSchema#string

Sanjay K Jain

http://www.w3.org/2001/XMLSchema#string

Stephanie L Davis

http://www.w3.org/2001/XMLSchema#string

William R Bishai

http://www.w3.org/2001/XMLSchema#string

P2860

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

Applications of bioluminescence imaging to the study of infectious diseases

Ipr1 gene mediates innate immunity to tuberculosis.

Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals

Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.

Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum

Structure and function of mammalian facilitative sugar transporters.

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Positron emission tomography imaging in nonmalignant thoracic disorders.

P304

4879-4884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00789-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19738022

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

2772305

http://www.w3.org/2001/XMLSchema#string